Intensity Therapeutics, Inc. operates as biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. The company is headquartered in Shelton, Connecticut and currently employs 5 full-time employees. The company went IPO on 2023-06-30. The company is engaged in developing treatments that address both the regional and systemic nature of a patient’s cancer. Its platform creates patented anti-cancer product candidates comprising active anti-cancer agents and amphiphilic molecules. Its lead product candidate, INT230-6, comprises three components: cisplatin, a proven anti-cancer cytotoxic agent, vinblastine sulfate, also a proven anti-cancer cytotoxic agent, and an amphiphilic molecule (SHAO) which enables the two cytotoxic agents to disperse through a tumor and diffuse into cancer cells following a direct intratumoral injection. Its pipeline consists of INVINCIBLE-3 Study, a Phase 3 open-label, randomized study testing the superiority INT230-6 used as monotherapy compared to the standard of care drugs in 2nd and 3rd line treatment for certain soft tissue sarcoma subtypes, a Phase 2 clinical study in metastatic triple negative breast cancer.
Follow-Up Questions
¿Quién es el CEO de Intensity Therapeutics Inc?
Mr. Lewis Bender es el Chairman of the Board de Intensity Therapeutics Inc, se unió a la empresa desde 2012.
¿Qué tal es el rendimiento del precio de la acción INTS?
El precio actual de INTS es de $0.5451, ha increased un 1.88% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Intensity Therapeutics Inc?
Intensity Therapeutics Inc pertenece a la industria Biotechnology y el sector es Health Care
¿Cuál es la capitalización bursátil de Intensity Therapeutics Inc?
La capitalización bursátil actual de Intensity Therapeutics Inc es $26.7M
¿Es Intensity Therapeutics Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 8 analistas han realizado calificaciones de análisis para Intensity Therapeutics Inc, incluyendo 2 fuerte compra, 7 compra, 2 mantener, 0 venta, y 2 fuerte venta